OSUR · ORASURE TECHNOLOGIES INC
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.
Cap structure and valuation
| Cap structure | |
|---|---|
| SP | $2.95 |
| SO | 68.8M |
| Options | 3.4M |
| Warrants | 0.0M |
| FD SO | 72.2M |
| MC | $213.1M |
| Cash | $177.0M |
| Total debt | $7.0M |
| EV | $43.1M |
| TTM Multiples | |
|---|---|
| EV / Revenue | 0.4x |
| EV / EBITDA | — |
| MC / Net Income | — |
| EV / FCF | — |
| MC / FCF | — |
MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-04-30. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative.
Financial statements
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Total Revenue | 27.93 | 26.76 | 27.09 | 31.24 |
| Revenue YoY % | (6.7%) | (28.5%) | (32.1%) | (42.5%) |
| Cost of Revenue | 16.12 | 15.79 | 15.31 | 18.08 |
| Gross Profit | 11.80 | 10.97 | 11.77 | 13.16 |
| Gross Profit YoY % | (4.0%) | (19.2%) | (31.0%) | (46.7%) |
| Gross Margin % | 42.3% | 41.0% | 43.5% | 42.1% |
| SG&A | 21.33 | 16.40 | 17.38 | 19.05 |
| R&D | 13.65 | 11.42 | 10.11 | 11.40 |
| Operating Expense | 35.07 | 31.07 | 27.86 | 31.18 |
| Operating Income | (23.27) | (20.10) | (16.09) | (18.03) |
| Operating Income YoY % | (31.1%) | (61.9%) | (168.2%) | (557.9%) |
| Operating Margin % | (83.3%) | (75.1%) | (59.4%) | (57.7%) |
| EBITDA | (20.93) | (17.70) | (13.64) | (15.50) |
| EBITDA Margin % | (74.9%) | (66.1%) | (50.3%) | (49.6%) |
| Pretax Income | (22.81) | (19.08) | (13.66) | (17.69) |
| Tax Provision | (0.43) | 0.21 | 0.05 | 2.00 |
| Net Income | (22.38) | (19.29) | (13.71) | (19.69) |
| Net Margin % | (80.1%) | (72.1%) | (50.6%) | (63.0%) |
| Diluted EPS | -$0.32 | -$0.27 | -$0.19 | -$0.26 |
| Basic EPS | -$0.32 | -$0.27 | -$0.19 | -$0.26 |
| Diluted Avg Shares | 69.7 | -0.6 | 73.0 | 74.5 |
| Basic Avg Shares | 69.7 | -0.6 | 73.0 | 74.5 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Total Revenue | 113.02 | 115.02 | 185.83 | 405.47 | 387.48 |
| Revenue YoY % | (1.7%) | (38.1%) | (54.2%) | 4.6% | — |
| Cost of Revenue | 65.31 | 66.82 | 106.44 | 233.82 | 239.04 |
| Gross Profit | 47.70 | 48.20 | 79.39 | 171.65 | 148.44 |
| Gross Profit YoY % | (1.0%) | (39.3%) | (53.7%) | 15.6% | — |
| Gross Margin % | 42.2% | 41.9% | 42.7% | 42.3% | 38.3% |
| SG&A | 74.16 | 73.79 | 77.20 | 94.51 | 117.44 |
| R&D | 46.58 | 42.53 | 26.05 | 33.73 | 36.24 |
| Operating Expense | 125.19 | 120.17 | 107.64 | 138.97 | 170.59 |
| Operating Income | (77.49) | (71.97) | (28.25) | 32.68 | (22.16) |
| Operating Income YoY % | (7.7%) | (154.8%) | (186.4%) | 247.5% | — |
| Operating Margin % | (68.6%) | (62.6%) | (15.2%) | 8.1% | (5.7%) |
| EBITDA | (67.76) | (61.78) | (17.38) | 53.62 | (6.85) |
| EBITDA Margin % | (60.0%) | (53.7%) | (9.4%) | 13.2% | (1.8%) |
| Pretax Income | (73.24) | (66.93) | (17.70) | 56.26 | (15.68) |
| Tax Provision | 1.82 | 1.80 | 1.80 | 2.60 | 1.46 |
| Net Income | (75.07) | (68.73) | (19.50) | 53.66 | (17.13) |
| Net Margin % | (66.4%) | (59.8%) | (10.5%) | 13.2% | (4.4%) |
| Diluted EPS | -$1.04 | -$0.94 | -$0.26 | $0.72 | -$0.24 |
| Basic EPS | -$1.04 | -$0.94 | -$0.26 | $0.73 | -$0.24 |
| Diluted Avg Shares | 69.7 | 73.5 | 74.4 | 74.4 | 72.5 |
| Basic Avg Shares | 69.7 | 73.5 | 74.4 | 73.3 | 72.5 |
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Cash & Equivalents | 176.96 | 199.28 | 216.48 | 234.58 |
| Receivables | 24.81 | 22.20 | 24.30 | 25.90 |
| Inventory | 30.31 | 31.06 | 33.40 | 33.38 |
| Total Current Assets | 240.78 | 261.91 | 283.01 | 301.44 |
| Net PPE | 37.86 | 39.18 | 40.80 | 42.16 |
| Goodwill | 43.05 | 43.36 | 41.31 | 41.74 |
| Total Assets | 379.17 | 403.17 | 423.10 | 445.04 |
| Accounts Payable | 10.63 | 6.52 | 6.36 | 6.38 |
| Total Current Liabilities | 44.08 | 39.80 | 40.25 | 42.35 |
| Total Liabilities | 65.84 | 62.34 | 61.12 | 64.31 |
| Retained Earnings | (194.54) | (172.16) | (152.88) | (139.16) |
| Total Equity | 313.32 | 340.83 | 361.98 | 380.72 |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 176.96 | 199.28 | 267.76 | 290.41 | 83.98 |
| Receivables | 24.81 | 22.20 | 23.82 | 40.17 | 70.80 |
| Inventory | 30.31 | 31.06 | 34.20 | 47.61 | 95.70 |
| Total Current Assets | 240.78 | 261.91 | 333.22 | 386.46 | 325.19 |
| Net PPE | 37.86 | 39.18 | 45.10 | 45.42 | 59.41 |
| Goodwill | 43.05 | 43.36 | 40.33 | 35.70 | 35.10 |
| Total Assets | 379.17 | 403.17 | 479.66 | 482.85 | 444.18 |
| Accounts Payable | 10.63 | 6.52 | 8.17 | 13.15 | 38.02 |
| Total Current Liabilities | 44.08 | 39.80 | 33.48 | 39.54 | 69.06 |
| Total Liabilities | 65.84 | 62.34 | 69.32 | 52.17 | 79.75 |
| Retained Earnings | (194.54) | (172.16) | (103.43) | (83.93) | (137.59) |
| Total Equity | 313.32 | 340.83 | 410.34 | 430.67 | 364.43 |
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Net Income | (22.38) | (19.29) | (13.71) | (19.69) |
| D&A | 2.34 | 2.40 | 2.45 | 2.53 |
| Stock-Based Comp | 2.77 | 1.46 | 2.83 | 3.17 |
| Operating Cash Flow | (13.89) | (9.00) | (10.07) | (10.22) |
| CapEx | (0.91) | (0.92) | (0.92) | (1.94) |
| Investing Cash Flow | (0.91) | (4.42) | (0.82) | (1.94) |
| Stock Buyback | (5.00) | (5.04) | (5.00) | (5.00) |
| Financing Cash Flow | (6.28) | (5.11) | (5.08) | (5.80) |
| Free Cash Flow | (14.81) | (9.92) | (10.99) | (12.16) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Net Income | (75.07) | (68.73) | (19.50) | 53.66 | (17.13) |
| D&A | 9.72 | 10.19 | 10.87 | 20.94 | 15.31 |
| Stock-Based Comp | 10.23 | 10.15 | 11.92 | 10.73 | 11.62 |
| Operating Cash Flow | (43.19) | (49.02) | 27.37 | 141.58 | (47.20) |
| CapEx | (4.69) | (4.20) | (3.80) | (5.80) | (6.77) |
| Investing Cash Flow | (8.09) | (6.81) | (39.03) | 66.15 | 21.09 |
| Stock Buyback | (20.04) | (15.04) | 0.00 | 0.00 | (2.25) |
| Financing Cash Flow | (22.27) | (16.94) | (4.18) | (3.02) | (3.83) |
| Free Cash Flow | (47.88) | (53.22) | 23.58 | 135.78 | (53.98) |
| 3/31/26 | 12/31/25 | 9/30/25 | 6/30/25 | |
|---|---|---|---|---|
| Current Ratio | 5.46 | 6.58 | 7.03 | 7.12 |
| Quick Ratio | 4.77 | 5.80 | 6.20 | 6.33 |
| Debt / Equity | 0.21 | 0.18 | 0.17 | 0.17 |
| EBITDA Margin % | (74.9%) | (66.1%) | (50.3%) | (49.6%) |
| Working Capital | 196.70 | 222.11 | 242.76 | 259.09 |
| Net Debt | — | — | — | — |
| ROE % | (7.1%) | (5.7%) | (3.8%) | (5.2%) |
| ROA % | (5.9%) | (4.8%) | (3.2%) | (4.4%) |
| LTM | 12/31/25 | 12/31/24 | 12/31/23 | 12/31/22 | |
|---|---|---|---|---|---|
| Current Ratio | 5.46 | 6.58 | 9.95 | 9.77 | 4.71 |
| Quick Ratio | 4.77 | 5.80 | 8.93 | 8.57 | 3.32 |
| Debt / Equity | 0.21 | 0.18 | 0.17 | 0.12 | 0.22 |
| EBITDA Margin % | (60.0%) | (53.7%) | (9.4%) | 13.2% | (1.8%) |
| Working Capital | 196.70 | 222.11 | 299.74 | 346.92 | 256.13 |
| Net Debt | — | — | — | — | — |
| ROE % | (24.0%) | (20.2%) | (4.8%) | 12.5% | (4.7%) |
| ROA % | (19.8%) | (17.0%) | (4.1%) | 11.1% | (3.9%) |
Insider activity (last 2 years)
| Date Filed | Reporter | Relationship | Trans. Date | Code | Shares | Price | Total Value |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Boyd Steven Kyle | Director | 2026-05-14 | P | 25,000 | $2.99 | $74,750 |
| 2026-05-14 | Boyd Steven Kyle | Director | 2026-05-13 | P | 25,000 | $3.02 | $75,500 |
| 2026-05-14 | Marmora Lelio | Director | 2026-05-13 | F | (28,406) | $3.02 | -$85,786 |
| 2026-05-14 | McMahon Robert W. | Director | 2026-05-13 | F | (22,888) | $3.02 | -$69,122 |
| 2026-05-14 | Gagliano Nancy J | Director | 2026-05-13 | F | (21,305) | $3.02 | -$64,341 |
| 2026-05-14 | Boyd Steven Kyle | Director | 2026-05-12 | P | 25,000 | $2.98 | $74,500 |
| 2026-05-14 | Bertrand John D. | Director | 2026-05-12 | A | 33,661 | — | $0 |
| 2026-03-30 | Boyd Steven Kyle | Director | 2026-03-26 | A | 5,246 | $3.10 | $16,249 |
| 2026-03-30 | Boyd Steven Kyle | Director | 2026-03-26 | F | (1,416) | $3.10 | -$4,386 |
| 2026-03-23 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2026-03-20 | P | 32,300 | $2.93 | $94,600 |
| 2026-03-23 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2026-03-20 | P | 32,300 | $2.93 | $94,597 |
| 2026-03-19 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2026-03-02 | A | 42,982 | — | $0 |
| 2026-03-19 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2026-03-01 | A | 14,183 | — | $0 |
| 2026-03-19 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2026-03-01 | F | (4,062) | $3.04 | -$12,359 |
| 2026-03-19 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2026-03-01 | F | (10,817) | $3.04 | -$32,911 |
| 2026-03-16 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2026-03-13 | P | 22,021 | $3.00 | $66,030 |
| 2026-03-16 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2026-03-13 | P | 22,022 | $3.00 | $66,033 |
| 2026-03-03 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2026-03-02 | A | 88,348 | — | $0 |
| 2026-03-03 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2026-03-02 | A | 355,464 | — | $0 |
| 2026-03-03 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2026-03-01 | A | 26,814 | — | $0 |
| 2026-03-03 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2026-03-01 | F | (7,639) | $3.04 | -$23,242 |
| 2026-03-03 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2026-03-01 | F | (20,745) | $3.04 | -$63,117 |
| 2026-03-03 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2026-03-01 | A | 129,032 | — | $0 |
| 2026-03-03 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2026-03-01 | F | (56,116) | $3.04 | -$170,733 |
| 2026-03-03 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2026-03-01 | F | (122,655) | $3.04 | -$373,178 |
| 2025-12-19 | Kenny John P. | Director | 2025-12-17 | A | 10,286 | $2.46 | $25,304 |
| 2025-12-02 | Gagliano Nancy J | Director | 2025-11-28 | P | 2,100 | $2.37 | $4,982 |
| 2025-12-02 | Boyd Steven Kyle | Director | 2025-10-28 | A | 34,632 | — | $0 |
| 2025-09-26 | Kenny John P. | Director | 2025-09-24 | A | 6,118 | $3.27 | $20,000 |
| 2025-08-11 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2025-08-08 | F | (12,524) | $2.78 | -$34,817 |
| 2025-08-04 | McMahon Robert W. | Director | 2025-07-31 | F | (7,317) | $3.21 | -$23,451 |
| 2025-06-25 | Kenny John P. | Director | 2025-06-24 | A | 6,657 | $3.01 | $20,026 |
| 2025-06-05 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-06-04 | A | 335,710 | — | $0 |
| 2025-06-05 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-06-04 | F | (146,000) | $2.90 | -$423,400 |
| 2025-06-05 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-06-04 | F | (47,249) | $2.90 | -$137,022 |
| 2025-05-15 | Kenny John P. | Director | 2025-05-14 | A | 71,017 | — | $0 |
| 2025-05-15 | Gagliano Nancy J | Director | 2025-05-14 | A | 71,017 | — | $0 |
| 2025-05-15 | McMahon Robert W. | Director | 2025-05-14 | A | 71,017 | — | $0 |
| 2025-05-15 | Marmora Lelio | Director | 2025-05-14 | A | 71,017 | — | $0 |
| 2025-05-15 | Shulkin David | Director | 2025-05-14 | A | 71,017 | — | $0 |
| 2025-05-15 | Aspinall Mara G. | Director | 2025-05-14 | A | 71,017 | — | $0 |
| 2025-05-15 | Gagliano Nancy J | Director | 2025-05-13 | F | (4,387) | $2.65 | -$11,637 |
| 2025-05-15 | McMahon Robert W. | Director | 2025-05-13 | F | (6,427) | $2.65 | -$17,048 |
| 2025-05-15 | Marmora Lelio | Director | 2025-05-13 | F | (7,977) | $2.65 | -$21,159 |
| 2025-05-15 | Shulkin David | Director | 2025-05-13 | F | (4,999) | $2.65 | -$13,260 |
| 2025-05-15 | Aspinall Mara G. | Director | 2025-05-13 | F | (6,666) | $2.65 | -$17,682 |
| 2025-03-27 | Kenny John P. | Director | 2025-03-25 | F | (1,385) | $3.55 | -$4,920 |
| 2025-03-04 | Weber Kathleen Gallagher | Officer (Chief Product Officer) | 2025-03-01 | A | 88,148 | — | $0 |
| 2025-03-04 | Weber Kathleen Gallagher | Officer (Chief Product Officer) | 2025-03-01 | F | (8,312) | $3.63 | -$30,152 |
| 2025-03-04 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2025-03-01 | A | 100,647 | — | $0 |
| 2025-03-04 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2025-03-01 | F | (10,673) | $3.63 | -$38,716 |
| 2025-03-04 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-03-01 | A | 462,414 | — | $0 |
| 2025-03-04 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-03-01 | F | (62,382) | $3.63 | -$226,291 |
| 2025-03-04 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2025-03-01 | A | 52,166 | — | $0 |
| 2025-03-04 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2025-03-01 | F | (5,030) | $3.63 | -$18,246 |
| 2025-03-03 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-02-28 | P | 28,670 | $3.49 | $100,027 |
| 2025-03-03 | Gagliano Nancy J | Director | 2025-02-27 | P | 12,750 | $3.08 | $39,270 |
| 2025-02-27 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2025-02-27 | P | 78,625 | $3.15 | $247,378 |
| 2025-02-27 | Kenny John P. | Director | 2025-02-27 | P | 47,659 | $3.17 | $151,217 |
| 2025-02-27 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2025-02-27 | P | 64,000 | $3.15 | $201,683 |
| 2025-02-27 | Marmora Lelio | Director | 2025-02-27 | P | 7,000 | $3.06 | $21,420 |
| 2025-02-04 | Weber Kathleen Gallagher | Officer (Chief Product Officer) | 2025-02-01 | A | 35,083 | — | $0 |
| 2025-02-04 | Weber Kathleen Gallagher | Officer (Chief Product Officer) | 2025-02-01 | F | (9,945) | $3.95 | -$39,308 |
| 2025-02-04 | Weber Kathleen Gallagher | Officer (Chief Product Officer) | 2025-02-01 | F | (3,801) | $3.95 | -$15,023 |
| 2025-02-04 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2025-02-01 | F | (766) | $3.95 | -$3,028 |
| 2025-01-07 | Weber Kathleen Gallagher | Officer (Chief Product Officer) | 2025-01-05 | F | (6,859) | $3.77 | -$25,893 |
| 2025-01-07 | Anthony Michele Marie | Officer (SVP Finance & CAO) | 2025-01-05 | F | (4,822) | $3.77 | -$18,203 |
| 2024-09-10 | Kenny John P. | Director | 2024-09-06 | A | 23,256 | $4.30 | $100,001 |
| 2024-08-09 | McGrath Kenneth J | Officer (Chief Financial Officer) | 2024-08-08 | F | (19,118) | $4.59 | -$87,752 |
| 2024-06-06 | EGLINTON MANNER CARRIE | Director, Officer (President & CEO) | 2024-06-04 | F | (401,618) | $4.65 | -$1,867,524 |
| 2024-05-16 | Marmora Lelio | Director | 2024-05-14 | F | (3,960) | $5.26 | -$20,849 |
| 2024-05-16 | Marmora Lelio | Director | 2024-05-14 | A | 19,943 | — | $0 |
| 2024-05-16 | McMahon Robert W. | Director | 2024-05-14 | A | 19,943 | — | $0 |
| 2024-05-16 | Gagliano Nancy J | Director | 2024-05-14 | A | 19,943 | — | $0 |
| 2024-05-16 | Shulkin David | Director | 2024-05-14 | F | (4,964) | $5.26 | -$26,135 |
| 2024-05-16 | Shulkin David | Director | 2024-05-14 | A | 19,943 | — | $0 |
| 2024-05-16 | Aspinall Mara G. | Director | 2024-05-14 | F | (6,619) | $5.26 | -$34,849 |
| 2024-05-16 | Aspinall Mara G. | Director | 2024-05-14 | A | 24,691 | — | $0 |
| 2024-05-16 | Datin James A | Director | 2024-05-14 | F | (5,364) | $5.26 | -$28,241 |